Cargando…
Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease
PURPOSE OF REVIEW: Although the HIV-infected population is living longer and getting older under current treatment regimens, significant challenges arise for health management as the infection is associated with various premature aging phenotypes, particularly increased incidence of cardiovascular d...
Autores principales: | El-Far, Mohamed, Tremblay, Cécile L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718258/ https://www.ncbi.nlm.nih.gov/pubmed/29045253 http://dx.doi.org/10.1097/COH.0000000000000426 |
Ejemplares similares
-
Impact of antiretroviral drugs on the microbiome: unknown answers to important questions
por: Pinto-Cardoso, Sandra, et al.
Publicado: (2018) -
Discovery medicine – the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine
por: Martin, Troy M., et al.
Publicado: (2023) -
Accelerating HIV vaccine development through meaningful engagement of local scientists and communities
por: Chinyenze, Kundai, et al.
Publicado: (2023) -
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023) -
Generating and measuring effective vaccine-elicited HIV-specific CD8(+) T cell responses
por: Borgo, Gina M., et al.
Publicado: (2023)